Inoculated mammary carcinoma-associated fibroblasts: Contribution to hormone independent tumor growth

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Fabris, Victoria T ^a   Sahores, Ana ^a   Vanzulli, Silvia I ^b   Colombo, Lucas ^c   Molinolo, Alfredo A ^d   Lanari, Claudia ^a   Lamb, Caroline A ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GREEN FLUORESCENT PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; SEX HORMONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER STAGING; CARCINOMA ASSOCIATED FIBROBLAST; CONTROLLED STUDY; DISEASE MODEL; EPITHELIUM CELL; FEMALE; FIBROBLAST; FROZEN SECTION; HORMONE DEPENDENCE; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; QUANTITATIVE STUDY; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BREAST TUMOR; CANCER TRANSPLANTATION; CELL COMMUNICATION; CELL PROLIFERATION; CELL SURVIVAL; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); NONOBESE DIABETIC MOUSE; PAGET NIPPLE DISEASE; PATHOLOGY; TIME; TRANSGENIC MOUSE; TUMOR CELL CULTURE; VASCULARIZATION;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL COMMUNICATION; CELL PROLIFERATION; CELL SURVIVAL; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GONADAL STEROID HORMONES; GREEN FLUORESCENT PROTEINS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TIME FACTORS; TUMOR BURDEN; TUMOR CELLS, CULTURED;

EID: 77953504733     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-293     Document Type: Article

References (32)

1. Hu M, Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev 2008, 18:27-34. 10.1016/j.gde.2007.12.006, 2467152, 18282701.
2. Sappino AP, Skalli O, Jackson B, Schurch W, Gabbiani G. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 1988, 41:707-712. 10.1002/ijc.2910410512, 2835323.
3. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001, 1:46-54. 10.1038/35094059, 11900251.
4. Noel A, Pauw-Gillet MC, Purnell G, Nusgens B, Lapiere CM, Foidart JM. Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. Br J Cancer 1993, 68:909-915. 1968733, 8217606.
5. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348. 10.1016/j.cell.2005.02.034, 15882617.
6. Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R, Arteaga CL, Neilson EG, Hayward SW, Moses HL. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene 2005, 24:5053-5068. 10.1038/sj.onc.1208685, 15856015.
7. Duda DG, Fukumura D, Munn LL, Booth MF, Brown EB, Huang P, Seed B, Jain RK. Differential transplantability of tumor-associated stromal cells. Cancer Res 2004, 64:5920-5924. 10.1158/0008-5472.CAN-04-1268, 15342367.
8. Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y, Bauerlein EL, Hahn WC, Gelman RS, Allred C, Bissell MJ, Schnitt S, Polyak K. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008, 13:394-406. 10.1016/j.ccr.2008.03.007, 18455123.
9. Lanari C, Molinolo AA, Pasqualini CD. Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice. Cancer Lett 1986, 33:215-223. 10.1016/0304-3835(86)90027-3, 2947675.
10. Molinolo AA, Lanari C, Charreau EH, Sanjuan N, Pasqualini CD. Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors. J Natl Cancer Inst 1987, 79:1341-1350.
11. Lanari C, Lamb CA, Fabris VT, Helguero LA, Soldati R, Bottino MC, Giulianelli S, Cerliani JP, Wargon V, Molinolo A. The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr Relat Cancer 2009, 16:333-350. 10.1677/ERC-08-0244, 19190078.
12. Molinolo A, Simian M, Vanzulli S, Pazos P, Lamb C, Lanari C. Involvement of EGF in medroxyprogesterone acetate (MPA)-induced mammary gland hyperplasia and its role in MPA-induced mammary tumors in BALB/c mice. Cancer Lett 1998, 126:49-57. 10.1016/S0304-3835(97)00527-2, 9563648.
13. Giulianelli S, Cerliani JP, Lamb CA, Fabris VT, Bottino MC, Gorostiaga MA, Novaro V, Gongora A, Baldi A, Molinolo A, Lanari C. Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis. Int J Cancer 2008, 123:2518-2531. 10.1002/ijc.23802, 18767044.
14. Institute of Laboratory Animal Resources C.o.L.S.N.R.C Guide for the Care and Use of Laboratory Animals 1996, Washington, D.C.: National Academy Press, Institute of Laboratory Animal Resources C.o.L.S.N.R.C.
15. Lanari C, Kordon E, Molinolo A, Pasqualini CD, Charreau EH. Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines. Int J Cancer 1989, 43:845-850. 10.1002/ijc.2910430518, 2523869.
16. Dran G, Luthy IA, Molinolo AA, Charreau EH, Pasqualini CD, Lanari C. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma. Breast Cancer Res Treat 1995, 35:173-186. 10.1007/BF00668207, 7647339.
17. Fabris VT, Benavides F, Conti C, Merani S, Lanari C. Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model. Cancer Genet Cytogenet 2005, 161:130-139. 10.1016/j.cancergencyto.2005.02.008, 16102583.
18. Lanari C, Montecchia MF, Pazos P, Simian M, Vanzulli S, Lamb C, Molinolo AA. Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors. Medicina (B Aires) 1997, 57:55-69.
19. Lamb CA, Helguero LA, Giulianelli S, Soldati R, Vanzulli SI, Molinolo A, Lanari C. Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice. Breast Cancer Res 2005, 7:R1111-R1121. 10.1186/bcr1345, 1410760, 16457691.
20. Presta M, Andres G, Leali D, Dell'era P, Ronca R. Inflammatory cells and chemokines sustain FGF2-induced angiogenesis. Eur Cytokine Netw 2009, 20:39-50.
21. Udagawa T, Puder M, Wood M, Schaefer BC, D'Amato RJ. Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells. FASEB J 2006, 20:95-102. 10.1096/fj.04-3669com, 16394272.
22. Picard O, Rolland Y, Poupon MF. Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases. Cancer Res 1986, 46:3290-3294.
23. Yashiro M, Ikeda K, Tendo M, Ishikawa T, Hirakawa K. Effect of organ-specific fibroblasts on proliferation and differentiation of breast cancer cells. Breast Cancer Res Treat 2005, 90:307-313. 10.1007/s10549-004-5364-z, 15830145.
24. Gartner MF, Wilson EL, Dowdle EB. Fibroblast-dependent tumorigenicity of melanoma xenografts in athymic mice. Int J Cancer 1992, 51:788-791. 10.1002/ijc.2910510520, 1612785.
25. Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 2007, 13:1211-1218. 10.1038/nm1649, 17906636.
26. Shojaei F, Zhong C, Wu X, Yu L, Ferrara N. Role of myeloid cells in tumor angiogenesis and growth. Trends Cell Biol 2008, 18:372-378. 10.1016/j.tcb.2008.06.003, 18614368.
27. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK, Seed B. Tumor induction of VEGF promoter activity in stromal cells. Cell 1998, 94:715-725. 10.1016/S0092-8674(00)81731-6, 9753319.
28. Studebaker AW, Storci G, Werbeck JL, Sansone P, Sasser AK, Tavolari S, Huang T, Chan MW, Marini FC, Rosol TJ, Bonafe M, Hall BM. Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res 2008, 68:9087-9095. 10.1158/0008-5472.CAN-08-0400, 18974155.
29. Dong J, Grunstein J, Tejada M, Peale F, Frantz G, Liang WC, Bai W, Yu L, Kowalski J, Liang X, Fuh G, Gerber HP, Ferrara N. VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis. EMBO J 2004, 23:2800-2810. 10.1038/sj.emboj.7600289, 514949, 15229650.
30. Kim BG, Kim HJ, Park HJ, Kim YJ, Yoon WJ, Lee SJ, Ryoo HM, Cho JY. Runx2 phosphorylation induced by fibroblast growth factor-2/protein kinase C pathways. Proteomics 2006, 6:1166-1174. 10.1002/pmic.200500289, 16421932.
31. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995, 154:8-20. 10.1159/000147748, 8714286.
32. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428. 10.1172/JCI39104, 2689101, 19487818.